Microbicide Trials Network stops tenofovir arm of study after findings show drug less effective than anticipated

“The Microbicide Trials Network (MTN), which is funded by the U.S. National Institutes of Health, on Wednesday announced that it decided to stop one arm of a study involving more than 5,000 women in South Africa, Zimbabwe, and Uganda” after “an interim review of the ongoing trial by an independent monitoring board found that the [...]

Circadian files IND with FDA for VGX-100 for the treatment of cancer patients with solid tumors

Circadian Technologies Limited (ASX: CIR, OTCQX:CKDXY) is extremely proud to announce that its 100% owned subsidiary, Vegenics Pty Ltd, has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) to initiate clinical studies of VGX-100. The first trial (Phase I) will involve the treatment of a variety of different [...]

Disclosure By Drug Companies Of Results Of Clinical Trials Necessary, Even When They Won’t Lead To A Product

Drug companies sponsoring human trials of possible new medications have ethical responsibilities to study participants and to science to disclose the results of their clinical research - even when product development is no longer being pursued, says a commentary co-authored by a leading UC Davis drug researcher published online in Science Translational Medicine…

Galectin posts new corporate video on galectin-inhibiting therapeutics to treat fibrosis and cancer

Galectin Therapeutics Inc. today announced that it posted a new corporate presentation video to its website, www.galectintherapeutics.com, that highlights the Company’s leadership position in developing galectin-inhibiting therapeutics to treat fibrosis and cancer.

FDA, other regulatory and international partners complete International Internet Week of Action

The U.S. Food and Drug Administration and other regulatory and international partners have completed the International Internet Week of Action (IIWA), a cooperative effort to curb online sales and distribution of counterfeit and illegal medical products.

MU researchers examine use of propranolol to improve primary traits linked with autism

Most drug therapy interventions for people with autism have targeted psychiatric problems, including aggression, anxiety and obsessive behavior. Now, University of Missouri researchers are examining the use of propranolol to improve the primary traits associated with autism - difficulty with normal social skills, language and repetitive behaviors.

Study highlights importance of prior planning before introduction of new vaccines

Proper planning before the introduction of new vaccines into a developing country’s active immunization program could prevent storage problems and transportation bottlenecks that decrease the availability of existing vaccines by as much as two-thirds, according to a University of Pittsburgh study.

Patients with chronic hepatitis C less likely to take medications over time

Patients being treated for chronic hepatitis C become less likely to take their medications over time, according to a new study from the Perelman School of Medicine at the University of Pennsylvania.

APhA encourages patients to discuss with pharmacist about pain and medications

In honor of Pain Awareness Month, the American Pharmacists Association (APhA) encourages patients to have an open discussion with their pharmacist about their pain and the medications they take for pain.

Survey: 25% of employers have little or no understanding of specialty pharmacy, costs

Twenty-five percent of employers have little or no understanding of specialty pharmacy and 53 percent have only a moderate understanding of this challenging benefit according to a new survey released by the non-profit Midwest Business Group on Health (MBGH), one of the nation’s leading business groups of private and public employers.